Jackson Financial Inc. — Financial Data
Annual figures from SEC EDGAR XBRL filings (10-K)
These figures are extracted directly from XBRL-tagged financial statements that Jackson Financial Inc. filed with the SEC as part of its annual 10-K reports. XBRL (eXtensible Business Reporting Language) is a structured data format the SEC requires for machine-readable financial disclosures. Values shown are as reported — negative figures indicate a loss and are shown in red.
Revenue
Total revenue from all business activities — the top line of the income statement. Represents all money earned before any expenses are deducted.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $6.68B | Feb 24, 2026 |
| FY2025 | Dec 31, 2024 | $3.27B | Feb 24, 2026 |
| FY2025 | Dec 31, 2023 | $3.08B | Feb 24, 2026 |
| FY2023 | Jan 1, 2023 | $9.86B | Feb 28, 2024 |
| FY2022 | Dec 31, 2022 | ($381.00M) | Mar 1, 2023 |
| FY2022 | Sep 30, 2022 | $4.02B | Mar 1, 2023 |
| FY2022 | Jun 30, 2022 | $6.55B | Mar 1, 2023 |
| FY2022 | Mar 31, 2022 | $4.36B | Mar 1, 2023 |
| FY2023 | Jan 1, 2022 | $6.36B | Feb 28, 2024 |
| FY2022 | Dec 31, 2021 | $1.73B | Mar 1, 2023 |
Net Income
The bottom-line profit — what remains after all operating expenses, interest, taxes, and other costs are deducted. A negative value means the company reported a net loss for the year.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $27.00M | Feb 24, 2026 |
| FY2025 | Dec 31, 2024 | $946.00M | Feb 24, 2026 |
| FY2025 | Dec 31, 2023 | $934.00M | Feb 24, 2026 |
| FY2023 | Jan 1, 2023 | $6.19B | Feb 28, 2024 |
| FY2022 | Dec 31, 2022 | ($710.00M) | Mar 1, 2023 |
| FY2022 | Sep 30, 2022 | $1.48B | Mar 1, 2023 |
| FY2022 | Jun 30, 2022 | $2.90B | Mar 1, 2023 |
| FY2022 | Mar 31, 2022 | $2.03B | Mar 1, 2023 |
| FY2023 | Jan 1, 2022 | $3.42B | Feb 28, 2024 |
| FY2022 | Dec 31, 2021 | $585.00M | Mar 1, 2023 |
Operating Cash Flow
Cash generated from core business operations — a more reliable measure of financial health than net income because it strips out non-cash items like depreciation and one-time charges.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $5.76B | Feb 24, 2026 |
| FY2025 | Dec 31, 2024 | $5.79B | Feb 24, 2026 |
| FY2025 | Dec 31, 2023 | $5.31B | Feb 24, 2026 |
| FY2023 | Jan 1, 2023 | $5.21B | Feb 28, 2024 |
| FY2024 | Dec 31, 2022 | $5.21B | Feb 26, 2025 |
| FY2023 | Jan 1, 2022 | $5.68B | Feb 28, 2024 |
| FY2023 | Dec 31, 2021 | $5.68B | Feb 28, 2024 |
| FY2022 | Dec 31, 2020 | $3.71B | Mar 1, 2023 |
| FY2021 | Dec 31, 2019 | $4.37B | Mar 7, 2022 |
Total Assets
The total value of everything the company owns or controls — cash, investments, receivables, property, equipment, and intangibles. Reported as of fiscal year end.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $352.59B | Feb 24, 2026 |
| FY2025 | Dec 31, 2024 | $338.45B | Feb 24, 2026 |
| FY2024 | Dec 31, 2023 | $330.26B | Feb 26, 2025 |
| FY2023 | Jan 1, 2023 | $314.98B | Feb 28, 2024 |
| FY2023 | Dec 31, 2022 | $314.98B | Feb 28, 2024 |
| FY2022 | Dec 31, 2021 | $375.56B | Mar 1, 2023 |
| FY2023 | Jan 1, 2021 | $355.51B | Feb 28, 2024 |
| FY2021 | Dec 31, 2020 | $353.46B | Mar 7, 2022 |
Total Liabilities
All financial obligations owed to outside parties — including debt, accounts payable, accrued expenses, and deferred revenue. Subtracting liabilities from total assets gives stockholders' equity.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $342.24B | Feb 24, 2026 |
| FY2025 | Dec 31, 2024 | $328.47B | Feb 24, 2026 |
| FY2024 | Dec 31, 2023 | $319.92B | Feb 26, 2025 |
| FY2023 | Jan 1, 2023 | $305.61B | Feb 28, 2024 |
| FY2023 | Dec 31, 2022 | $305.61B | Feb 28, 2024 |
| FY2022 | Dec 31, 2021 | $364.49B | Mar 1, 2023 |
| FY2023 | Jan 1, 2021 | $348.58B | Feb 28, 2024 |
| FY2021 | Dec 31, 2020 | $343.53B | Mar 7, 2022 |
Stockholders Equity
The net worth attributable to shareholders: total assets minus total liabilities. Also called book value. Can be negative if liabilities exceed assets, which is common in capital-intensive industries.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $9.95B | Feb 24, 2026 |
| FY2025 | Dec 31, 2024 | $9.76B | Feb 24, 2026 |
| FY2024 | Dec 31, 2023 | $10.17B | Feb 26, 2025 |
| FY2023 | Dec 31, 2022 | $8.65B | Feb 28, 2024 |
| FY2022 | Dec 31, 2021 | $10.39B | Mar 1, 2023 |
| FY2021 | Dec 31, 2020 | $9.43B | Mar 7, 2022 |
Retained Earnings
Cumulative net income kept by the company rather than distributed as dividends. A growing retained earnings balance indicates consistent profitability; a deficit indicates cumulative losses.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $7.47B | Feb 24, 2026 |
| FY2025 | Dec 31, 2024 | $7.71B | Feb 24, 2026 |
| FY2024 | Dec 31, 2023 | $7.04B | Feb 26, 2025 |
| FY2023 | Jan 1, 2023 | $6.40B | Feb 28, 2024 |
| FY2023 | Dec 31, 2022 | $6.40B | Feb 28, 2024 |
| FY2022 | Dec 31, 2021 | $2.81B | Mar 1, 2023 |
| FY2023 | Jan 1, 2021 | ($2.93B) | Feb 28, 2024 |
| FY2021 | Dec 31, 2020 | ($324.00M) | Mar 7, 2022 |
Cash & Equivalents
Highly liquid assets the company holds — cash on hand, bank balances, and short-term investments with maturities of three months or less. A key indicator of short-term financial health.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $5.70B | Feb 24, 2026 |
| FY2025 | Dec 31, 2024 | $3.77B | Feb 24, 2026 |
| FY2025 | Dec 31, 2023 | $2.69B | Feb 24, 2026 |
| FY2024 | Dec 31, 2022 | $4.30B | Feb 26, 2025 |
| FY2023 | Dec 31, 2021 | $2.62B | Feb 28, 2024 |
| FY2022 | Dec 31, 2020 | $2.02B | Mar 1, 2023 |
| FY2021 | Dec 31, 2019 | $1.94B | Mar 7, 2022 |
Long-Term Debt
Debt obligations due more than one year from the balance sheet date — bonds, term loans, and notes payable. High long-term debt relative to equity can signal elevated financial leverage.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $2.03B | Feb 24, 2026 |
| FY2025 | Dec 31, 2024 | $2.03B | Feb 24, 2026 |
| FY2024 | Dec 31, 2023 | $2.04B | Feb 26, 2025 |
| FY2023 | Dec 31, 2022 | $2.64B | Feb 28, 2024 |
| FY2022 | Dec 31, 2021 | $2.65B | Mar 1, 2023 |
| FY2021 | Dec 31, 2020 | $322.00M | Mar 7, 2022 |
EPS (Basic)
Net income divided by the weighted average shares outstanding. Basic EPS does not account for dilutive securities like options or convertible bonds — use diluted EPS for a more conservative view.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | 0 | Feb 24, 2026 |
| FY2025 | Dec 31, 2024 | 11 | Feb 24, 2026 |
| FY2025 | Dec 31, 2023 | 10 | Feb 24, 2026 |
| FY2023 | Jan 1, 2023 | 72 | Feb 28, 2024 |
| FY2022 | Dec 31, 2022 | (8) | Mar 1, 2023 |
| FY2022 | Sep 30, 2022 | 17 | Mar 1, 2023 |
| FY2022 | Jun 30, 2022 | 33 | Mar 1, 2023 |
| FY2022 | Mar 31, 2022 | 23 | Mar 1, 2023 |
| FY2023 | Jan 1, 2022 | 36 | Feb 28, 2024 |
| FY2022 | Dec 31, 2021 | 6 | Mar 1, 2023 |
EPS (Diluted)
Net income divided by the fully diluted share count — including all potential shares from options, warrants, and convertible instruments. The more conservative and widely cited EPS figure.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | 0 | Feb 24, 2026 |
| FY2025 | Dec 31, 2024 | 11 | Feb 24, 2026 |
| FY2025 | Dec 31, 2023 | 10 | Feb 24, 2026 |
| FY2023 | Jan 1, 2023 | 69 | Feb 28, 2024 |
| FY2022 | Dec 31, 2022 | (8) | Mar 1, 2023 |
| FY2022 | Sep 30, 2022 | 16 | Mar 1, 2023 |
| FY2022 | Jun 30, 2022 | 32 | Mar 1, 2023 |
| FY2022 | Mar 31, 2022 | 22 | Mar 1, 2023 |
| FY2023 | Jan 1, 2022 | 36 | Feb 28, 2024 |
| FY2022 | Dec 31, 2021 | 6 | Mar 1, 2023 |
Shares Outstanding
Total common shares issued and held by all shareholders, excluding treasury shares. Combined with market price gives market capitalization.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | 66.83M | Feb 24, 2026 |
| FY2025 | Dec 31, 2024 | 73.38M | Feb 24, 2026 |
| FY2025 | Dec 31, 2023 | 78.66M | Feb 24, 2026 |
| FY2024 | Dec 31, 2022 | 82.69M | Feb 26, 2025 |
| FY2023 | Dec 31, 2021 | 88.69M | Feb 28, 2024 |
| FY2022 | Dec 31, 2020 | 94.46M | Mar 1, 2023 |
| FY2021 | Dec 31, 2019 | 37.79M | Mar 7, 2022 |
Dividends Paid
Cash dividends distributed to common shareholders during the period. Shown as a positive value despite being a cash outflow in the SEC filing.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $223.00M | Feb 24, 2026 |
| FY2025 | Dec 31, 2024 | $211.00M | Feb 24, 2026 |
| FY2025 | Dec 31, 2023 | $201.00M | Feb 24, 2026 |
| FY2024 | Dec 31, 2022 | $186.00M | Feb 26, 2025 |
| FY2023 | Dec 31, 2021 | $50.00M | Feb 28, 2024 |
| FY2022 | Dec 31, 2020 | $0 | Mar 1, 2023 |
| FY2021 | Dec 31, 2019 | $0 | Mar 7, 2022 |